<DOC>
	<DOCNO>NCT02254070</DOCNO>
	<brief_summary>To assess influence different degree renal impairment safety , tolerability , pharmacodynamics pharmacokinetics 1.0 mg BIBT 986 BS give single dose infusion 30 minute comparison normal renal function</brief_summary>
	<brief_title>Influence Different Degrees Renal Impairment Safety , Tolerability , Pharmacodynamics Pharmacokinetics BIBT 986 BS Subjects With Normal Renal Function Patients With Different Degrees Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Healthy male female subject determine result screen creatinine clearance &gt; 80 mL/min ( Group 1 ) Renally impaired male female subject determine result screen follow creatinine clearance result : creatinine clearance 5180 mL/min ( Group 2 ) creatinine clearance 3150 mL/min ( Group 3 ) creatinine clearance ≤ 30 mL/min ( Group 4 ) subject require hemodialysis ( Group 5 ) Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; =18 &lt; =75 year BMI &gt; =18.5 &lt; =29.9 kg/m2 Groups 1+2 BMI &gt; =18.5 &lt; =32 kg/m2 Groups 3 , 4 5 Any find medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Abnormal PT , TT , aPTT ( must within normal range one repeat test ) , thrombocytes &lt; 150000/μl ( two repeat first test ) Evidence haematuria either macroscopically detectable microscopic urinalysis ( normal microscopic result ore one repeated test ) Evidence blood dyscrasia , haemorrhagic diathesis , severe thrombocytopenia , cerebrovascular haemorrhage , bleed tendency associate active ulceration overt bleed gastrointestinal , respiratory genitourinary tract disease condition haemorrhagic tendency ( e.g . cerebral aneurysm , dissect aorta , CNS trauma , retinopathy , nephrolithiasis ) Recent contemplate diagnostic therapeutic procedure potential uncontrollable bleeding ( e.g . spinal puncture , lumbar block anaesthesia , surgery central nervous system ( CNS ) eye surgery result large open surface ) within 14 day drug administration clinical trial Occult blood 1 3 subsequent faecal sample collect prestudy examination Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator For woman childbearing potential : reliable contraception ( accept method intra uterine device , hormonal contraceptive , bilateral tubal ligation , hysterectomy , condom ) pregnancy ( know detect positive pregnancy test ) breast feeding period Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , within 14 day prior administration trial Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 ml , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality Veins unsuited i.v . puncture administration prolong infusion either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . ) Renally impaired subject ( Group 2 , 3 , 4 5 ) meet follow criterion enter trial : Moderate severe concurrent liver function impairment ( e.g. , due hepatorenal syndrome ) Gastrointestinal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Abnormal value PT , TT , aPTT thrombocyte consider investigator one coinvestigators clinically relevant Hemoglobin concentration &lt; 9 mg/dl Evidence blood dyscrasia , haemorrhagic diathesis , severe thrombocytopenia , cerebrovascular haemorrhage , bleed tendency associate active ulceration overt bleed gastrointestinal , respiratory genitourinary tract disease condition haemorrhagic tendency ( e.g . cerebral aneurysm , dissect aorta , CNS trauma , retinopathy , nephrolithiasis ) consider investigator one coinvestigators clinically relevant Recent contemplate diagnostic therapeutic procedure potential uncontrollable bleeding ( e.g . spinal puncture , lumbar block anaesthesia , surgery CNS eye surgery result large open surface ) within 14 day drug administration clinical trial Occult blood 1 3 subsequent faecal sample collect prestudy examination Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator For woman childbearing potential : reliable contraception ( accept method intra uterine device , hormonal contraceptive , bilateral tubal ligation , hysterectomy , condom ) pregnancy ( know detect positive pregnancy test ) breast feeding period Faecal occult blood ( FOB ) 1 3 subsequent sample collect prestudy examination Use drug influence blood clot within 14 day prior administration trial ( except heparin hemodialysis patient ) Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 ml , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality Veins unsuited i.v . puncture administration prolong infusion either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>